{"id":"NCT02052141","sponsor":"Shire","briefTitle":"Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema","officialTitle":"A Phase 3, Multicenter, Randomized, Single-Blind, Dose-Ranging, Crossover Study to Evaluate the Safety and Efficacy of Intravenous Administration of CINRYZEÂ® (C1 Esterase Inhibitor [Human]) for the Prevention of Angioedema Attacks in Children 6 to 11 Years of Age With Hereditary Angioedema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-20","primaryCompletion":"2017-05-04","completion":"2017-05-04","firstPosted":"2014-01-31","resultsPosted":"2018-08-28","lastUpdate":"2021-06-03"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Hereditary Angioedema (HAE)"],"interventions":[{"type":"BIOLOGICAL","name":"CINRYZE 500","otherNames":[]},{"type":"BIOLOGICAL","name":"CINRYZE 1000","otherNames":[]}],"arms":[{"label":"500/1000","type":"EXPERIMENTAL"},{"label":"1000/500","type":"EXPERIMENTAL"}],"summary":"Primary Objective - To assess the relative efficacy of two dose levels of CINRYZE (500 Units and 1000 Units) administered by intravenous (IV) injection every 3 or 4 days to prevent angioedema attacks in children 6 to 11 years of age with hereditary angioedema (HAE).\n\nSecondary Objectives - To assess the safety and tolerability, characterize the pharmacokinetics (PK) and pharmacodynamics (PD), and assess the immunogenicity of two dose levels of CINRYZE administered by IV injection in children 6 to 11 years of age with HAE.","primaryOutcome":{"measure":"Normalized Number of Angioedema Attacks Per Month in a Treatment Period","timeFrame":"From start of treatment up to 12 weeks during each treatment period","effectByArm":[{"arm":"Treatment A (500 U CINRYZE)","deltaMin":1.2,"sd":1.53},{"arm":"Treatment B (1000 U CINRYZE)","deltaMin":0.7,"sd":1.35}],"pValues":[{"comp":"OG000 vs OG001","p":"0.03"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":8,"countries":["United States","Germany","Israel","Mexico","Romania"]},"refs":{"pmids":["28662509","36326435","30968444"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Hereditary angioedema","Viral upper respiratory tract infection","Erythema marginatum","Abdominal pain","Nausea"]}}